GZR
1-[(1S)-1-(4-fluorophenyl)ethyl]-3-[[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]methylidene]piperidin-2-one
Find entries where: GZR
is present as a standalone ligand in 1 entries
Chemical Component Summary | |
---|---|
Name | 1-[(1S)-1-(4-fluorophenyl)ethyl]-3-[[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]methylidene]piperidin-2-one |
Synonyms | E-2012 |
Identifiers | 1-[(1~{S})-1-(4-fluorophenyl)ethyl]-3-[[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]methylidene]piperidin-2-one |
Formula | C25 H26 F N3 O2 |
Molecular Weight | 419.491 |
Type | NON-POLYMER |
Isomeric SMILES | Cc1cn(cn1)c2ccc(cc2OC)C=C3CCCN(C3=O)[C@@H](C)c4ccc(cc4)F |
InChI | InChI=1S/C25H26FN3O2/c1-17-15-28(16-27-17)23-11-6-19(14-24(23)31-3)13-21-5-4-12-29(25(21)30)18(2)20-7-9-22(26)10-8-20/h6-11,13-16,18H,4-5,12H2,1-3H3/b21-13+/t18-/m0/s1 |
InChIKey | PUOAETJYKQITMO-LANLRWRYSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 57 |
Chiral Atom Count | 1 |
Bond Count | 60 |
Aromatic Bond Count | 17 |
Drug Info: DrugBank
DrugBank ID | DB05171 |
---|---|
Name | E-2012 |
Groups | investigational |
Description | E-2012 is a gamma secretase modulator that is being evaluated as a potential new treatment for Alzheimer's disease. |
Synonyms | E-2012 |
Indication | Investigated for use/treatment in alzheimer's disease. |
Categories |
|
CAS number | 870843-42-8 |
Drug Targets
Name | Target Sequence | Pharmacological Action | Actions |
---|---|---|---|
Gamma-secretase subunit APH-1A | MGAAVFFGCTFVAFGPAFALFLITVAGDPLRVIILVAGAFFWLVSLLLAS... | unknown | |
Gamma-secretase subunit PEN-2 | MNLERVSNEEKLNLCRKYYLGGFAFLPFLWLVNIFWFFREAFLVPAYTEQ... | unknown |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
Resource Name | Reference |
---|---|
PubChem | 57354968 |